Table 3. REMODELING CHANGES BY BASELINE VIABILITY.

Paired Data (Winsorized for LV ED^*, LV ES^† and WM^‡)

	SEVERELY REDUCED VIABILITY < 40%		MODERATE RETAINED VIABILITY≥ 40%
	(N = 33		(N = 79)		p-value
	n	Mean±SD	n	Mean±SD
LV ED Volume (ml)
Baseline	29	156.5±44.6	76	114.0±37.0	<0.001
1 yr	29	148.1±47.8	76	113.4±37.7	<0.001
Change (1yr-Baseline)	29	−8.3±21.9	76	0.57±28.0	0.18
p-value (within group)		0.05		0.86
LV ES Volume (ml)
Baseline	29	95.5±40.0	76	60.2±29.7	<0.001
1 yr	29	88.6±41.0	76	55.7±28.9	<0.001
Change (1yr-Baseline)	29	−6.9±20.3	76	−4.5±20.6	0.60
p-value (within group)		0.08		0.06
Ejection Fraction (%)
Baseline	29	41.3±11.5	76	49.2±10.2	0.001
1 yr	29	42.7±13.3	76	53.6±10.6	<0.001
Change (1yr-Baseline)	29	1.4±7.0	76	4.4±7.0	0.05
p-value (within group)		0.30		<0.001
Wall Motion Score
Baseline	30	24.0±6.9	76	15.3±7.3	<0.001
1 yr	30	18.8±9.2	76	10.1±8.1	<0.001
Change (1yr-Baseline)	30	5.2±6.7	76	−5.2±6.8	0.98
p-value (within group)		<0.001		<0.001

^*LV ED=left ventricular end-diastolic dimension,

^†LV ES =ventricular end-systolic dimension,

^‡WM=wall motion